Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

508 public trials 143 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

EMD 521873 in Advanced Solid Tumors, MTD Finding

NCT01032681

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations
  • Universitäts-Klinikum Mainz III.Medizinische Klinik Mainz, Germany
  • Medizinische Klinik Universitätsklinikum Mannheim Medizinische Fakultät Mannheim Mannheim, Germany
  • Istituto Oncologico della Svizzera Italiana Ospedale Regionale Bellinzona e Valli (IOSI) Bellinzona, Switzerland
  • University of Lausanne Hospitals (CHUV) and Hospitals of Riveria-Chablais Lausanne, Switzerland
View Trial Details
Completed

Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)

NCT01292135

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +18 more
Locations
  • Dana Farber Cancer Center Boston, Massachusetts, United States
  • CLL Research and Treatment Program New Hyde Park, New York, United States
  • Weill Medical College of Cornell University New York, United States
  • University of Rochester Rochester, New York, United States
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma

NCT00394693

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Northwestern University Medical School Chicago, Illinois, United States
  • M.D. Anderson Cancer Center Houston, Texas, United States
  • Hopital Lapeyronie Montpellier, France
View Trial Details
Completed

Safety of PCI-32765 in Chronic Lymphocytic Leukemia

NCT01105247

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +18 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • New York Presbyterian Hosptial Cornell Med Center New York, United States
  • The Ohio State University Columbus, Ohio, United States
  • Willamette Valley Cancer Institute and Research Center Springfield, Oregon, United States
View Trial Details
Completed

Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma

NCT00849654

Conditions
B-cell Leukemia, B-cell Lymphoma, Blood Protein Disorders, +31 more
Locations
  • Stanford University School of Medicine Palo Alto, California, United States
  • University of Chicago Chicago, Illinois, United States
  • National Cancer Institute Bethesda, Maryland, United States
  • New York Prebyterian Hospital Cornell Medical Center New York, United States
View Trial Details

Related conditions